Blatt; Lawrence

Patent Applications and Registrations

Patent applications and USPTO patent grants for Blatt; Lawrence.The latest application filed is for "substituted nucleotide analogs".

Company Profile

1.1.27

Blatt; Lawrence - San Francisco CA
Blatt; Lawrence - South San Francisco CA
Blatt; Lawrence - Boulder CO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted Nucleotide Analogs App 20120070411 - Beigelman; Leonid ; et al.	2012-03-22
Compounds and methods for inhibiting hepatitis C viral replication Grant 8,119,592 - Beigelman , et al. February 21, 2	2012-02-21
2-5a Analogs And Their Methods Of Use App 20100331397 - Beigelman; Leonid ; et al.	2010-12-30
Substituted Nucleoside And Nucleotide Analogs App 20100249068 - Beigelman; Leonid ; et al.	2010-09-30
Protected Nucleotide Analogs App 20100240604 - Beigelman; Leonid ; et al.	2010-09-23
2-5a Analogs And Their Methods Of Use App 20090181921 - Blatt; Lawrence ; et al.	2009-07-16
Protected Nucleotide Analogs App 20090176732 - Beigelman; Leonid ; et al.	2009-07-09
Non-natural chemokine receptor ligands and methods of use thereof App 20090131312 - Blatt; Lawrence ; et al.	2009-05-21
Compounds And Methods For Inhibiting Hepatitis C Viral Replication App 20090093533 - Beigelman; Leonid ; et al.	2009-04-09
Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies App 20070026394 - Blatt; Lawrence ; et al.	2007-02-01
Oligonucleotide mediated inhibition of hepatitis B virus and hepatitis C virus replication App 20040127446 - Blatt, Lawrence ; et al.	2004-07-01
Method and reagent for inhibiting hepatitis B viral replication App 20040054156 - Draper, Kenneth ; et al.	2004-03-18
Nucleic acid mediated disruption of HIV fusogenic peptide interactions App 20040006035 - Macejak, Dennis ; et al.	2004-01-08
Method and reagent for the inhibition of NOGO and NOGO receptor genes App 20030203870 - Blatt, Lawrence ; et al.	2003-10-30
Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection App 20030171311 - Blatt, Lawrence ; et al.	2003-09-11
Conjugates and compositions for cellular delivery App 20030130186 - Vargeese, Chandra ; et al.	2003-07-10
Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection App 20030125270 - Blatt, Lawrence ; et al.	2003-07-03
Method and reagent for the inhibition of NOGO and NOGO receptor genes App 20030113891 - Blatt, Lawrence ; et al.	2003-06-19
Method and reagent for the treatment of Alzheimer's disease App 20030092003 - Blatt, Lawrence ; et al.	2003-05-15
Method and reagent for the inhibition of CD20 App 20030092646 - Blatt, Lawrence ; et al.	2003-05-15
Method and reagent for inhibiting hepatitis B virus replication App 20030068301 - Draper, Kenneth ; et al.	2003-04-10
Nucleic acid sensor molecules App 20030065155 - Usman, Nassim ; et al.	2003-04-03
Method and reagent for the inhibition of NOGO gene App 20030060611 - Blatt, Lawrence ; et al.	2003-03-27
Method and reagent for the treatment of cardiac disease App 20030050259 - Blatt, Lawrence ; et al.	2003-03-13
Nucleic acid sensor molecules App 20030008295 - Usman, Nassim ; et al.	2003-01-09
Nucleic acid sensor molecules App 20020102568 - Usman, Nassim ; et al.	2002-08-01
Enzymatic Nucleic Acid Treatment Of Diseases Or Conditions Related To Hepatitis C Virus Infection App 20020082225 - BLATT, LAWRENCE ; et al.	2002-06-27
Enzymatic nucleic acid treatment of disases or conditions related to hepatitis c virus infection App 20020013458 - Blatt, Lawrence ; et al.	2002-01-31

Company Registrations

SEC

0001242110

BLATT LAWRENCE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.